Sil'kis I G
Zh Vyssh Nerv Deiat Im I P Pavlova. 2008 Sep-Oct;58(5):521-39.
Existing data on hippocampal involvement in contextual memory and the fact that contextual memory is deranged during REM sleep dreams allowed us to assume that one of the reasons for this derangement could be a change in the efficacy of synaptic transmission in the hippocampus because of a rise (as compared to wakefulness) of acetylcholine, cortisol, and dopamine concentrations and lack of serotonin and norepinephrine. The earlier performed analysis showed that, during REM sleep, the LTD could be induced at all steps of the polysynaptic pathway through the hippocampal formation, whereas the LTP could be induced in the entorhinal inputs to hippocampal areas CA1 and CA3 and in associative connections within the CA3 field. We suggested that the effective signal transmission in each units of the polysynaptic pathway through the hippocampus is necessary for correct functioning of episodic memory and generation of neuronal representation of the context. During retrieval in the state of wakefulness, the representation of episodic context stored in the hippocampus could be activated together with the neuronal representations of episodic details stored in those neocortical areas wherein they were processed. It follows from the proposed mechanism that any neuromodulator or neuropeptide which promotes LTP in the polysynaptic hippocampal pathway can improve episodic memory. Since the consequences of the proposed mechanism agree with the known experimental data, this phenomenon can be used for the development of drugs improving episodic memory.
关于海马体参与情境记忆的现有数据,以及情境记忆在快速眼动睡眠梦境中会紊乱这一事实,使我们能够假定,这种紊乱的原因之一可能是由于乙酰胆碱、皮质醇和多巴胺浓度升高(与清醒状态相比)以及血清素和去甲肾上腺素缺乏,导致海马体中突触传递效率发生变化。早期进行的分析表明,在快速眼动睡眠期间,通过海马结构的多突触通路的所有步骤都可以诱导长时程抑制(LTD),而在海马区域CA1和CA3的内嗅输入以及CA3区域内的联合连接中可以诱导长时程增强(LTP)。我们认为,通过海马体的多突触通路中每个单元的有效信号传递对于情景记忆的正确运作和情境的神经元表征的产生是必要的。在清醒状态下进行检索时,存储在海马体中的情景情境表征可以与存储在那些对情景细节进行处理的新皮质区域中的情景细节的神经元表征一起被激活。从所提出的机制可以推断,任何促进海马体多突触通路中LTP的神经调质或神经肽都可以改善情景记忆。由于所提出机制的结果与已知的实验数据一致,这种现象可用于开发改善情景记忆的药物。